Avosina Medical Technologies India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-12-2024
- Paid Up Capital ₹ 1.00 M
as on 17-12-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 242.17%
(FY 2022)
- Profit 6720.96%
(FY 2022)
- Ebitda 2802.19%
(FY 2022)
- Net Worth 109.30%
(FY 2022)
- Total Assets 124.88%
(FY 2022)
About Avosina Medical Technologies India
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Alidad Arabshahi, Linda Burke, and Suresh Arumugam serve as directors at the Company.
- CIN/LLPIN
U74999TN2020FTC135942
- Company No.
135942
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
22 Jun 2020
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Avosina Medical Technologies India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Arumugam  | Whole-Time Director | 26-Mar-2021 | Current |
Alidad Arabshahi  | Director | 22-Jun-2020 | Current |
| Linda Burke | Director | 22-Jun-2020 | Current |
Financial Performance of Avosina Medical Technologies India.
Avosina Medical Technologies India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 242.17% increase. The company also saw a substantial improvement in profitability, with a 6720.96% increase in profit. The company's net worth Soared by an impressive increase of 109.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avosina Medical Technologies India?
Unlock access to Avosina Medical Technologies India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avosina Medical Technologies India?
Avosina Medical Technologies India has a workforce of 30 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avosina Medical Technologies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avosina Medical Technologies India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
